Regenerative medicine company Tengion (NASDAQ:TNGN) has always planned to take its novel tissue generating technology as far as early-stage clinical studies before finding a partner to finance later-stage work. The company’s lead program treating patients who have had their bladder removed is expected to finish phase 1 enrollment by year’s end. A preclinical kidney program […]
Regenerative medicine company Tengion (NASDAQ:TNGN) plans to start human studies on its experimental kidney disease treatment in 2013. Tengion said that it expects to file an investigational new drug application, or IND, with the U.S. Food and Drug Administration on its lead preclinical program in the first half of next year. Proof-of-concept data from the […]
Choosing the right software translates directly into better client management, operational efficiency and growth for your spa franchise. Discover which tool is best for your business.
Regenerative medicine company Tengion (NASDAQ:TNGN) has relocated its headquarters from Pennsylvania to North Carolina, where the company maintains R&D operations. The move to North Carolina comes nearly two months after Tengion announced a corporate restructuring that included scaling back its Pennsylvania footprint and focusing its resources on the R&D facility in Winston-Salem, North Carolina. The […]
Regenerative medicine company Tengion (NASDAQ:TNGN) is restructuring with moves that reduce headcount, focus operations on its North Carolina R&D arm and conserve enough cash to last another year. Tengion said the restructuring plan will allow the company to fund its lead development programs through key milestones next year while also cutting its spending. The company […]
Regenerative medicine is now Tim Bertram‘s work but in previous chapters of his career, he focused on drugs while working for large pharmaceutical companies such as Pfizer (NYSE:PFE), Smithkline Beecham Pharmaceuticals and Procter & Gamble (NYSE:PG). Bertram left big pharma seven years ago to join Tengion (NASDAQ:TNGN), whose tissue regeneration technology was originally developed at […]
Regenerative medicine company Tengion‘s (NASDAQ:TNGN) Chief Scientific Officer Timothy Bertram will handle CEO duties while the company searches for a new top executive. Former CEO Dr. Steven Nichtberger resigned from the company on June 30. No reason was given for the resignation, but the company had said in securities filings that his departure “is not […]
Outsourcing your medical coding can help ensure a healthy revenue cycle. Discover the best medical coding outsourcing companies and find the right one for you.
Regenerative medicine company Tengion (NASDAQ:TNGN) has been granted orphan drug designation on its technology that is initially being developed to help patients with bladder cancer. Tengion’s platform technology for organ regeneration can create organs and tissues that the body will recognize as its own. The technology is intended to offer an alternative to current practices […]